Press Releases

Date	Title	Company
17-Oct-2023	Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti-CD40 mAb) Phase I Trial at ESMO 2023	Businesswire
17-Oct-2023	Evident Vascular Exits Stealth with $35 Million Series A Funding to Develop Intravascular Imaging Platform	Businesswire
17-Oct-2023	Eckert & Ziegler Achieves Double-Digit Growth in Q3 versus Previous Year. Significant Jump in Sales also in First 9 Months, Earnings still Burdened by Special Items Compared to Same Period Last Year.	Eckert & Ziegler Strahlen- und Medizintechnik AG
17-Oct-2023	US Medical Protective Equipment Industry to Surge at 8.7% CAGR, Reaching $13.8 Billion by 2033to surge to US$ 13.8 Billion by the end of 2033, with a CAGR of 8.7%	MARKITWIRED
17-Oct-2023	Nucleus RadioPharma Secures $56 Million Series A Funding to Expand Production of Radiopharmaceutical Treatments for Cancer Patients	Businesswire
17-Oct-2023	North American Gene Synthesis Industry Anticipated to Expand at a Remarkable CAGR of 15.7%, Hitting US$1.3 Billion by 2033 \| FMI Insights	MARKITWIRED
17-Oct-2023	Babies with a low birthweight are four times more likely to develop fatty liver disease in later life, new study shows	, United European Gastroenterology (UEG)
17-Oct-2023	Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells	The Institute of Cancer Research
17-Oct-2023	Amolyt Pharma Announces Data on Prevalence of Bone Disease in Patients with Hypoparathyroidism and Favorable Bone Effects of Eneboparatide at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting	Amolyt Pharma
17-Oct-2023	Saama Signs New Agreement That Will Enable Artificial Intelligence-Driven Drug Development	Businesswire
17-Oct-2023	Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases	Businesswire
17-Oct-2023	VedaBio Launches with Over $40 Million to Revolutionize Molecular Detection	Businesswire
17-Oct-2023	Theriva™ Biologics Announces Presentation at ESMO Congress 2023 Featuring Survival Outcomes in Phase 1 Study Evaluating VCN-01 in Combination with Durvalumab in Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck	Theriva™ Biologics, Inc
17-Oct-2023	Fighting Counterfeiting in the Medical and Pharmaceutical Industry: Origify offers End-to-End Authentication	Bosch
17-Oct-2023	PharmaKure announces study success for novel blood test to identify biomarkers in patients with Alzheimer’s Disease	PharmaKure
17-Oct-2023	New publication shows XF-73 drug potent against 2,527 Staphylococcus isolates Largest study of its kind to date demonstrates effectiveness of XF-73 against all tested antibiotic resistant strains	Destiny Pharma
17-Oct-2023	PureTech to Present at Two Upcoming Investor Conferences	PureTech Health
17-Oct-2023	Cell Line Engineering Breakthrough Cuts Drug Development Times by Up To 12 Months	Promega Corporation
17-Oct-2023	Global Advanced Wound Management Industry is likely to register an average CAGR of 3.6% Leading to US$11.5 Billion by 2033 \| FMI Insights	MARKITWIRED
17-Oct-2023	Moberg Pharma’s Nomination Committee appointed	Moberg Pharma